GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O - Germany 

Ranking results:

Past rankings:

2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):800-900
2015
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Networking Rank (Reputation):800-900
Partner Constancy:500-600
Project Leadership Index:800-900
2013
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:100-200
Total Number of Projects:62
Total Project Funding:100-200
Partner Constancy:50
Project Leadership Index:69
Diversity Index:63
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:200-300
Total Number of Projects:59
Total Project Funding:100-200
Networking Rank (Reputation):100-200
Networking Rank (Reputation):100-200
Partner Constancy:41
Project Leadership Index:75
Diversity Index:39
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Total Project Funding:200-300
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Total Project Funding:300-400
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:600-700
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:500-600
Total Number of Projects:> 1000
Total Project Funding:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 42
As coordinator: 0
As participant: 42
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 28.533.725 74.982 4
2015 0 27.330.056 886.692 5
2013 0 110.298.259 5.799.012 12
2012 0 79.020.303 4.781.627 12
2011 0 45.085.160 2.440.800 7
2010 0 11.320.408 854.179 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITAIR MEDISCH CENTRUM UTRECHT8
KATHOLIEKE UNIVERSITEIT LEUVEN7
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN7
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
UNIVERSITAETSKLINIKUM HEIDELBERG6
UNIVERSITY COLLEGE LONDON6
ARTTIC5
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS5
KING'S COLLEGE LONDON5
STICHTING KATHOLIEKE UNIVERSITEIT5
UNIVERSITAETSKLINIKUM BONN5
UNIVERSITY OF BIRMINGHAM5
UNIVERSITY OF GLASGOW5
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM4
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI4
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV4
REGION HOVEDSTADEN4
STROKE ALLIANCE FOR EUROPE4
THE UNIVERSITY OF EDINBURGH4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK4
CLININFO S A3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
KAROLINSKA INSTITUTE3
MEDIZINISCHE UNIVERSITAET WIEN3
ROYAL COLLEGE OF SURGEONS IN IRELAND3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN3
THE UNIVERSITY OF LIVERPOOL3
THE UNIVERSITY OF NOTTINGHAM3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUS MAXIMILIANS UNIVERSITAT3
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS3
UNIVERSITY OF COPENHAGEN3
UPPSALA UNIVERSITET3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER3
ACADEMISCH ZIEKENHUIS GRONINGEN2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EMC MICROCOLLECTIONS2
ESSILOR INTERNATIONAL2
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA2
GENOME RESEARCH2
HACETTEPE UNIVERSITESI2
HOSPICES CIVILS DE LYON2
HYCULT BIOTECHNOLOGY BV2
INSTITUT GUSTAVE ROUSSY2
INSTITUTE OF PSYCHIATRY AND NEUROLOGY2
JULIUSMAXIMILIANS UNIVERSITAET WUERZBURG2
KLINIKUM DER UNIVERSITAET ZU KOELN2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
LEIDEN UNIVERSITY MEDICAL CENTER2
MAYO CLINIC2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
MONASH UNIVERSITY2
OSLO UNIVERSITETSSYKEHUS HF2
OULUN YLIOPISTO2
PHILIPPS UNIVERSITAET MARBURG2
SAMFUNDET FOLKHAELSAN I SVENSKA FINLAND RF2
STICHTING VUVUMC2
SYDDANSK UNIVERSITET2
TARTU ULIKOOL2
TECHNISCHE UNIVERSITAET DRESDEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO2
UNIVERSITA DEGLI STUDI DI VERONA2
UNIVERSITAET BASEL2
UNIVERSITAET LEIPZIG2
UNIVERSITAET ZU LUEBECK2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAIR ZIEKENHUIS ANTWERPEN2
UNIVERSITE DE LIEGE2
UNIVERSITEIT MAASTRICHT2
UNIVERSITEIT UTRECHT2
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN2
UNIVERSITY OF MELBOURNE2
UNIVERSITY OF SZEGED2
UNIVERSITY OF TURKU2
UNIVERSYTET MEDYCZNY W LODZI2
VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA2
VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINES SANTARISKIU KLINIKOS2
AARHUS UNIVERSITETSHOSPITAL1
ABITEP1
ACQUIFER1
ACTION ALLIES IN CARDIOVASCULAR TRIALS INITIATIVES AND ORGANIZEDNETWORKS ASSOCIATION1
ADDIS ABABA UNIVERSITY1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AGRIFOOD AND BIOSCIENCES INSTITUTE1
AGRIGES1
ALACRIS THERANOSTICS1
ALZHEIMER EUROPE1

Constancy:

Total number of partners: 583
Partner loyalty:
Frequent Partner: (> 2 projects): 170
Rare Partner: 413
Frequent / Rare Partner Ratio: 0.41

Project overview:

Start dateProjectacronymrolefundingpartners
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025
2016-01-01Small vessel diseases in a mechanistic perspective: Targets for Intervention Affected pathways and mechanistic exploitation for prevention of stroke and dementia SVDs-at-targetparticipant5.998.30013
2016-01-01Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis FOLSMARTparticipant4.993.83411
2016-01-01Ears, Eyes and Mind: The ‘SENSE-Cog Project’ to improve mental well-being for elderly Europeans with sensory impairment SENSE-Cogparticipant6.541.59120
2015-11-01RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities RELENTparticipant5.999.43115
2015-11-01Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A HemAcureparticipant5.564.3958
2015-07-01Diamond materials for the photocatalytic conversion of CO2 to fine chemicals and fuels using visible light DIACATparticipant3.872.9809
2015-06-01PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke PRECIOUSparticipant5.994.00017
2015-01-01Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes TREGenerationparticipant5.899.2508
2013-11-01Labeling of Enalapril from Neonates up to Adolescents LENAparticipant5.999.99112
2013-11-01Targets and biomarkers for antiepileptogenesis EPITARGETparticipant11.999.97518
2013-10-01Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope EU-CERT-ICDparticipant5.999.56219
2013-10-01Collaborative European NeuroTrauma Effectiveness Research in TBI CENTER-TBIparticipant29.998.90338
2013-10-01Personalised Prognostic Tools for Early Psychosis Management PRONIAparticipant6.000.00011
2013-10-01Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified. CFMATTERSparticipant5.999.74812
2013-09-01Neurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing FEMNAT-CDparticipant5.999.24117
2013-09-01Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock CULPRIT-SHOCKparticipant5.999.14517
2013-09-01"MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy" EPIMIRNAparticipant11.586.85816
2013-08-01New approaches in the development of Hypoallergenic implant material in Orthopaedics: steps to personalised medicine HYPORTHparticipant5.282.6008
2013-05-01Donor T Cells for Immune Control T-CONTROLparticipant5.682.5365
2013-01-01Bioactivated hierarchical hydrogels as zonal implants for articular cartilage regeneration HYDROZONESparticipant9.749.70016
2012-12-01Systems medicine of chronic inflammatory bowel disease SYSMEDIBDparticipant11.999.99812
2012-11-01Emerging mental health systems in low- and middle-income countries EMERALDparticipant5.798.17312
2012-10-01Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and non-drug Therapy in Older peRsons SENATORparticipant5.938.94712
2012-10-01European Consortium for High-Throughput Research in Rare Kidney Diseases EURENOMICSparticipant11.994.56728
2012-10-01Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD) DSD-LIFEparticipant2.999.95616
2012-09-01Resource Preservation by Application of BIOefFECTORs in European Crop Production BIOFECTORparticipant5.999.82123
2012-07-01Bottom-up reconstitution of a biomimetic bioartificial liver RE-LIVERparticipant4.234.8775
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01Developmental Origins of Healthy and Unhealthy Ageing: The Role of Maternal Obesity DORIANparticipant2.999.97310
2012-01-01EUROPEAN FORENSIC GENETICS Network of Excellence EUROFORGEN-NOEparticipant6.613.68017
2012-01-01Disaster Training Curriculum DITACparticipant3.498.66813
2012-01-01A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease NILVADparticipant5.999.97817
2011-12-01Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial WAKE-UPparticipant11.599.98713
2011-11-01Epilepsy Pharmacogenomics: delivering biomarkers for clinical use EpiPGXparticipant5.997.99615
2011-10-01A Treatment-Oriented Research Project of NCL Disorders as a Major Cause of Dementia in Childhood DEM-CHILDparticipant2.998.79513
2011-10-01Cardiovascular Risk from Exposure to Low-dose and Low-dose-rate Ionizing Radiation PROCARDIOparticipant2.998.38713
2011-10-01A novel generation of skin substitutes to clinically treat a broad spectrum of severe skin defects EuroSkinGraftparticipant5.996.0188
2011-02-01European Sequencing and Genotyping Infrastructure ESGIparticipant9.499.99911
2011-01-01European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults ENS@T-CANCERparticipant5.993.97816
2010-11-01Infectious triggers of chronic autoimmunity INTRICATEparticipant5.965.08612
2010-10-01Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn The HIP Trialparticipant5.355.32216

Alias institution names:

  • GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG
  • GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O